Yauba Saidu | Immunization financing | Best Researcher Award

Dr. Yauba Saidu | Immunization financing | Best Researcher Award

Dr. Yauba Saidu at Clinton health Access Initiative, Cameroon

๐Ÿ‘จโ€๐ŸŽ“ Professional Profile

๐ŸŒŸ Current Position

Dr. Yauba Saidu serves as the Project Coordinator for the Building a National Medical Oxygen Strategy for Cape Verde and is also the Founder and President of the One Health Pastoral Initiative. In addition, he coordinates projects focused on strengthening human resources for health in the Central African Republic and protects chemotherapy drug quality in sub-Saharan Africa.

๐ŸŽ“ Early Academic Pursuits

Dr. Saidu earned his MD in General Medicine in 2007, followed by an MSc in Vaccinology and Pharmaceutical Clinical Development in 2011. He continued to enhance his expertise with a Ph.D. in Life Sciences (Global Health option) in 2023, and he recently completed a Certificate Program in One Health from the University of Florida in 2024.

๐Ÿ’ผ Professional Endeavors

Dr. Saiduโ€™s career spans multiple high-impact roles in public health. Since 2021, he has been the Country Director for the Clinton Health Access Initiative in Cameroon, alongside his role as the National Coordinator for The Lancet NCDI Poverty Commission. His experience also includes significant positions at the Medical Research Council Unit in The Gambia and various roles in the Clinton Health Access Initiative, where he contributed to numerous health programs.

๐Ÿ”ฌ Contributions and Research Focus

With over 75 research papers and 2 book chapters to his name, Dr. Saidu has made significant contributions to global health, particularly in areas such as immunization services, chemotherapy drug quality, and public health strategies. His research emphasizes the intersection of health systems and the impact of non-communicable diseases in resource-limited settings.

๐ŸŒ Impact and Influence

Dr. Saidu’s work has garnered recognition, including his designation as a Knight of the Cameroon Order of Valor in 2022. His leadership in various health initiatives has had a profound impact on health outcomes in Cameroon and across sub-Saharan Africa.

๐Ÿ“š Academic Cites

His research has received over 470 citations, achieving an H-index of 10, reflecting his influence in the field. His notable publications include contributions to vaccinology and climate change and health system sustainability.

๐Ÿ› ๏ธ Technical Skills

Dr. Saidu possesses a diverse set of technical skills, including program management, clinical trial coordination, and expertise in vaccinology and public health policy. His ability to navigate complex health systems and drive initiatives for improved health access is a hallmark of his career.

๐Ÿ‘จโ€๐Ÿซ Teaching Experience

As a student supervisor at the University of Buea, Dr. Saidu actively mentors the next generation of healthcare professionals, imparting his knowledge and experience in global health challenges.

๐Ÿ•Š๏ธ Legacy and Future Contributions

Dr. Saidu’s commitment to improving health outcomes in Africa positions him as a pivotal figure in global health. His ongoing projects aim to strengthen healthcare systems, expand access to essential medicines, and address the unique health challenges faced by vulnerable populations. As he continues to drive impactful health initiatives, Dr. Saidu is poised to leave a lasting legacy in the field of global health.

 

๐Ÿ“– Top Noted Publications

ย Anticipating and strategizing to address potential bottlenecks during clinical research projects in sub-Saharan Africa: a case for adapting approaches and tools used in the entrepreneurial and development sectors

Authors: Saidu, Y., Nchinjoh, S.C., Adidja, A., Ndom, P., Liebermann, M.
Journal: Trials
Year: 2024

Functional availability of medical oxygen for the management of hypoxaemia in Cameroon: A nationwide facility-based cross-sectional survey

Authors: Saidu, Y., Ndip, A.V., Diaby, O., Balkissou, A.D., Wiwa, O.
Journal: Journal of Global Health
Year: 2024

Climate change in Africa case studies: Role of healthcare and sustainable interventions

Authors: Umesi, A., Ubiame, O., Saidu, Y., Paul Jaiyeola, O., Darkwah, A.F.
Journal: Routledge Handbook of Climate Change and Health System Sustainability
Year: 2024

COVID-19 vaccination implementation in 52 African countries: trajectory and implications for future pandemic preparedness

Authors: Wariri, O., Afolabi, M.O., Mukandavire, C., Uthman, O.A., Kampmann, B.
Journal: BMJ Global Health
Year: 2023

The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroonโ€™s Expanded program on Immunization

Authors: Saidu, Y., Gu, J., Ngenge, B.M., Clemens, S.A.C., Clemens, R.
Journal: Human Resources for Health
Year: 2023

Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality

Authors: Saidu, Y., Gu, J., Ngenge, B.M., Clemens, S.A.C., Clemens, R.
Journal: BMC Health Services Research
Year: 2023

ย Beyond the numbers: An in-depth look at Cameroon’s fifth national COVID-19 vaccination campaign through geographical and gender lenses

Authors: Amani, A., Njoh, A.A., Atuhebwe, P., Chaiban, T., Gueye, A.S.
Journal: Vaccine
Year: 2023

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

๐Ÿ‘จโ€๐ŸŽ“ Professional Profile

๐ŸŽ“ Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

๐Ÿข Professional Endeavors

Dr. Vaughanโ€™s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for womenโ€™s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

๐ŸŒŸ Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

๐ŸŒ Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

๐Ÿ“š Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

๐Ÿ”ง Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

๐Ÿ‘ฉโ€๐Ÿซ Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

๐Ÿ… Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

๐Ÿ“– Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021